Paralysis Pipeline Review and Products Development Market By Companies and Drugs for H2 2015

Nov 05, 2015, 10:30 ET from Life Science Industry Research

PUNE, India, November 5, 2015 /PRNewswire/ --

New market research titled "Paralysis - Pipeline Review, H2 2015" providing an overview of the Paralysis's therapeutic pipeline from across the world is now available with LifeScienceIndustryResearch.com.

This report provides comprehensive information on the therapeutic development for Paralysis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Paralysis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report on H2 2015 pipeline review of Paralysis with 20 market data tables and 12 figures, spread across 51 pages is available at http://www.lifescienceindustryresearch.com/paralysis-pipeline-review-h2-2015.html .

Companies discussed in this report includes Asahi Kasei Pharma Corp., Immunome Inc., Marathon Pharmaceuticals, LLC, Neuralstem, Inc. and Ultragenyx Pharmaceutical Inc. Drugs Profiles discussed in this report includes BNZ-1321, elcatonin, flunarizine hydrochloride, Monoclonal Antibody Conjugates for Paralysis, NSI-566, REM-1086 and UX-007.

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Paralysis and reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. The report reviews key players involved in the therapeutics development for Paralysis and enlists all their major and minor projects summarizing all the dormant and discontinued pipeline projects. A review of the Paralysis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, a detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Paralysis pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products.

Order a copy of Paralysis - Pipeline Review, H2 2015 report @ http://www.lifescienceindustryresearch.com/purchase?rname=66993 .

Another report on pharmaceuticals market, titled Allergic Asthma - Pipeline Review, H2 2015 provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies. Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. Also, identify and understand important and diverse types of therapeutics under development for Allergic Asthma. The researcher plan mergers and acquisitions effectively by identifying key players of the most promising pipeline. The report devise corrective measures for pipeline projects by understanding Allergic Asthma pipeline depth and focus of Indication therapeutics. It develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. In the end the report modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. The Allergic Asthma - Pipeline Review, H2 2015 report is available at http://www.lifescienceindustryresearch.com/allergic-asthma-pipeline-review-h2-2015.html.

More reports on Pharmaceuticals are available at http://www.lifescienceindustryresearch.com/category/pharmaceuticals .

About Us:   

LifeScienceIndustryResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:

G+ / Google Plus: https://plus.google.com/112612135957880308475/about

Twitter: https://twitter.com/LifeSciReports

Facebook: https://www.facebook.com/lifescienceindustryresearch

RSS / Feeds: http://www.lifescienceindustryresearch.com/feed/

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@lifescienceindustryresearch.com


SOURCE Life Science Industry Research